Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Financing Activities (2020 - 2026)

Bioventus filings provide 6 years of Cash from Financing Activities readings, the most recent being -$28.4 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 33.62% to -$28.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$62.1 million, a 13.85% decrease, with the full-year FY2025 number at -$62.1 million, down 13.85% from a year prior.
  • Cash from Financing Activities hit -$28.4 million in Q4 2025 for Bioventus, down from -$20.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $176.3 million in Q4 2021 to a low of -$62.2 million in Q3 2023.
  • Median Cash from Financing Activities over the past 5 years was -$2.1 million (2023), compared with a mean of $9.6 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 1884.86% in 2021 and later plummeted 306007.14% in 2024.
  • Bioventus' Cash from Financing Activities stood at $176.3 million in 2021, then tumbled by 103.08% to -$5.4 million in 2022, then skyrocketed by 99.74% to -$14000.0 in 2023, then plummeted by 306007.14% to -$42.9 million in 2024, then skyrocketed by 33.62% to -$28.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$28.4 million (Q4 2025), -$20.0 million (Q3 2025), and -$14.7 million (Q2 2025) per Business Quant data.